Natural Health Trends Corp. — FY2016 Form 10-K
Business and period: International direct-selling and e-commerce company selling NHT Global wellness, herbal, beauty, lifestyle and home products. Fiscal year ended December 31, 2016; the filing also reports unaudited fourth-quarter results. Sales are overwhelmingly international and concentrated in Hong Kong, substantially all of which are delivered to members in China.
Financial performance
| Metric | FY2016 | FY2015 |
|---|---|---|
| Net sales | $287.7 million | $264.9 million |
| Gross profit / margin | $232.8 million / 80.9% | $210.8 million / 79.6% |
| Operating income / margin | $64.1 million / 22.3% | $47.9 million / 18.1% |
| Net income / margin | $55.1 million / 19.2% | $47.2 million / 17.9% |
| Diluted EPS | $4.83 | $3.82 |
| Operating cash flow | $53.2 million | $81.3 million |
| Cash and cash equivalents, year-end | $125.9 million | $104.9 million |
| Working capital, year-end | $84.1 million | $56.2 million |
FY2016 sales rose 9%; net income rose 17%. Cost of sales fell to 19.1% of sales from 20.4%, while commissions declined to 43.5% from 47.8% of sales. SG&A increased 20% to $43.2 million, largely due to event and training costs, professional fees, and credit-card fees. The income-tax provision increased to $9.0 million from $0.6 million, reflecting greater foreign profitability and repatriation of foreign earnings, partly offset by the release of the remaining U.S. deferred-tax-asset valuation allowance.
Fourth quarter: Net sales were $62.3 million versus $73.7 million in Q4 2015; operating income was $20.0 million versus $13.9 million, and net income was $19.0 million versus $13.7 million. Diluted EPS was $1.70 versus $1.13.
At year-end, total assets were $148.1 million and stockholders’ equity was $82.4 million. The balance sheet lists no borrowings; total liabilities were $65.6 million. Cash from operations fell 35% year over year, primarily due to timing of commission payments, greater use of member eWallets and U.S. taxes paid on repatriated earnings. Cash increased by $21.0 million after $23.7 million of share repurchases and $6.9 million of dividends. The current ratio was 2.47:1.
Material changes and management commentary
- Active members increased to 118,960 from 109,360. Hong Kong sales grew 7% to $263.5 million, while China e-commerce sales more than doubled to $9.1 million. New Wellness products contributed approximately $11.2 million to FY2016 sales growth.
- Management said sales growth was constrained by temporary Chinese government measures ahead of the G20 Summit, the absence of a comparable incentive-trip promotion offered in 2015, and the yuan’s 7% depreciation against the Hong Kong dollar, which reduced Chinese members’ purchasing power.
- Hong Kong represented 91.6% of reported sales. Management intends to prioritize Greater China and markets where existing members can support recruitment, including Southeast Asia, while beginning investments in Central and South America.
- The company applied for a China direct-selling license but could not predict if or when it would be granted. It said a license could provide incremental sales opportunities but would entail additional fixed costs.
- Management stated that cash on hand and operating cash flow should fund normal operations and commitments for the foreseeable future. No specific revenue or earnings guidance was provided.
Risks, contingencies and unusual items
- China regulatory exposure: The company does not hold a China direct-selling license. Its Hong Kong e-commerce model serving members in China and its separate China retail platform face regulatory scrutiny and interpretation risk; adverse action could disrupt operations or require changes to the business model.
- Litigation: A securities class action alleging misleading statements about China operations survived a motion to dismiss; the company filed its answer in February 2017 and says it will defend the claims. Two shareholder derivative cases make related allegations and were stayed pending the class action. Damages sought are indeterminate.
- Concentration and supply: Premium Noni Juice and Enhanced Essential Probiotics each generated more than 10% of revenue and each was sourced from a single supplier. The company also cited concentration in a small number of key member networks. A supplier agreement requires average annual purchases of at least $9.4 million over three years, with a potential cure payment if minimums are not met.
- Foreign exchange: The yuan’s depreciation affected member purchasing power; the company does not hedge short-term currency exposure. Most sales are outside North America, and Hong Kong sales dominate the business.
- Tax and capital return: The company repatriated $19.8 million to the U.S. in Q1 2016 and paid $8.8 million in income taxes during the year. It declared $0.61 per share in dividends for FY2016 and repurchased 903,031 shares for $23.7 million. A further $0.44 per-share dividend was declared in January 2017 and paid in March.
- The company disclosed limited product-liability insurance, extensive product and direct-selling regulation, and risks from member conduct, product concentration, and reliance on third-party manufacturers. Management and the auditor reported effective internal control over financial reporting at December 31, 2016.
Important facts for investors to verify
- Whether China regulatory scrutiny, the license application, or related litigation changes the company’s ability to serve Chinese members through its current channels.
- Whether Hong Kong sales and key member networks remain stable given the company’s geographic and distribution concentration.
- Whether growth in newer products and markets can offset reliance on the two major products and their single suppliers.
- Whether operating cash generation remains sufficient after commissions, eWallet balances, taxes, dividends, repurchases and planned China investment.
- How future repatriations, tax assessments and changes in foreign exchange affect the effective tax rate and reported earnings.